🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
480 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

120 mcg (100% DV)
✅ Within RDA (1.0× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.12mg

Other Ingredients

organic extra virgin Olive Oil Soft-Gelatin Capsule

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested use consume one or more capsules daily or as recommended by your physician. This product is most effective when used as part of a healthy diet and active lifestyle. For questions about the use of this product call 800.332.7799.

⚠️ Warnings & Precautions

Contains no additives or common allergens Contains no milk, soy, yeast, corn, wheat, gluten, sodium, salt, sugar, cholesterol, color, preservative, common allergens, genetically modified (GMO) ingredients or manufacturing additives.

🧪 Formulation Notes

Vitamin K's most active form

Andrew Lessman's Vitamin K2 MK-7 120 provides the most active and beneficial form of Vitamin K-2, Menaquinone-7 (MK-7). Vitamin K2 MK-7 is now recognized as essential for bone and heart health through its role in regulating calcium metabolism. The “K” in Vitamin K2 MK-7's name stems from the role of Vitamin K-1 in blood clotting, since it was discovered in Germany where “Koagulation” is spelled with a K. Vitamin K2 MK-7's unique importance instead relates to its scientifically established central role in calcium utilization and thus bone, heart and cardiovascular health. Essentially, Vitamin K2 MK-7 promotes the retention of calcium in healthy bone while discouraging its being deposited in other tissues causing undesirable calcification of arteries, heart valves, etc. By discouraging calcification, Vitamin K2 MK-7 promotes flexible, resilient arteries and heart valves, which is a defining characteristic of cardiovascular health. In short, Vitamin K2 MK-7 acts like a “traffic cop” directing calcium to the vital tissues where it is required while keeping it out of those where it is not desired. Since we all must consume calcium daily our healthy bones and flexible arteries require Vitamin K2 MK-7. Sadly, there is no significant source of Vitamin K2 MK-7 in the typical American diet making supplementation the only reliable method of acquiring this essential vitamin.

Contains no milk, soy, yeast, corn, wheat, gluten, sodium, salt, sugar, cholesterol, color, preservative, common allergens, genetically modified (GMO) ingredients or manufacturing additives.

Promotes optimum heart, bone and circulatory health

Additional Information

For over 40 years unsurpassed purity, quality and efficacy 100% solar production Zero carbon footprint Andrew Lessman, founder Questions? Reorders? 800.800.1200 www.ProCapsLabs.com www.HSN.com 800.944.9999 www.QVC.com 800.345.1515 100% solar

Product Details

UPC / SKU 791777
DSLD Entry Date 2022-10-24
Product Type Vitamin
Form Capsule
DSLD ID 275295
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →